CCM
MRK icon

Compass Capital Management’s Merck MRK Stock Holding History

Compass Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.9M Sell
589,768
-92,259
-14% -$10.7M 4.29% 1
2025
Q4 		$71.8M Sell
682,027
-104,841
-13% -$9.84M 3.99% 4
2025
Q3 		$66M Buy
786,868
+32,011
+4% +$2.64M 3.49% 7
2025
Q2 		$59.8M Buy
754,857
+156,359
+26% +$12.4M 3.2% 15
2025
Q1 		$53.7M Buy
598,498
+111,151
+23% +$10.4M 3.53% 25
2024
Q4 		$48.5M Buy
487,347
+22,838
+5% +$2.35M 3.18% 24
2024
Q3 		$52.7M Buy
464,509
+23,290
+5% +$2.77M 3.34% 25
2024
Q2 		$54.6M Sell
441,219
-12,880
-3% -$1.66M 3.66% 20
2024
Q1 		$59.9M Buy
454,099
+5,992
+1% +$739K 3.87% 16
2023
Q4 		$48.9M Buy
448,107
+12,400
+3% +$1.29M 3.46% 23
2023
Q3 		$44.9M Sell
435,707
-19,548
-4% -$2.11M 3.52% 23
2023
Q2 		$52.5M Buy
455,255
+12,815
+3% +$1.46M 3.78% 17
2023
Q1 		$47.1M Buy
+442,440
New +$47.8M 3.6% 22
2020
Q1 		– Sell
-4,232
Closed -$367K – 41
2019
Q4 		$367K Buy
4,232
+1,509
+55% +$124K 0.04% 37
2019
Q3 		$219K Buy
2,723
+103
+4% +$8.26K 0.03% 39
2019
Q2 		$210K Sell
2,620
-44
-2% -$3.37K 0.03% 40
2019
Q1 		$211K Buy
+2,664
New +$199K 0.03% 39
2017
Q3 		– Sell
-3,559
Closed -$218K – 41
2017
Q2 		$218K Hold
3,559
– – 0.04% 40
2017
Q1 		$216K Buy
+3,559
New +$216K 0.04% 43
2014
Q1 		– Sell
-4,198
Closed -$201K – 57
2013
Q4 		$201K Buy
+4,198
New +$192K 0.04% 58
2013
Q3 		– Sell
-4,859
Closed -$215K – 56
2013
Q2 		$215K Buy
+4,859
New +$217K 0.05% 51

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Compass Capital Management's MRK Position: Q1 2026 in Review

Compass Capital Management reduced its Merck (MRK) stake by 14% in Q1 2026, selling an estimated $10.7M and leaving 589,768 shares worth $70.9M. The position accounts for 4.29% of the portfolio, ranked #1.

Compass Capital Management first reported a position in MRK in Q2 2013 and has held it in 21 quarters since. The position peaked at $71.8M in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Compass Capital Management held 589,768 shares of Merck worth $70.9M as of Q1 2026.
  • Compass Capital Management sold 92,259 Merck shares in Q1 2026, an estimated $10.7M.
  • Merck made up 4.29% of Compass Capital Management's portfolio in Q1 2026, its #1 holding.
  • Compass Capital Management first reported a position in Merck in Q2 2013 and has held it in 21 quarters since.
  • Compass Capital Management's Merck position peaked at $71.8M in Q4 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Compass Capital Management's 13F filing for Q1 2026, filed 21 May 2026.